About 200 billion per year in China, dysmenorrhea health market
Medical authorities, according to a British survey noted that women in the world, 80% had varying degrees of dysmenorrhea. Oxford University gynecologist Dr. Kennedy Institute of meeting scientific achievement in the UK, said: "two thirds of women suffer from menstrual pain, pain and unable to work due to three-quarters." Pamabrom for the treatment of dysmenorrhea than 50 years of clinical application history, its market potential should not be overlooked
Period, according to the National Women's Survey of physical constants Collaborative Group, women suffer from varying degrees in 80% of menstrual syndrome, dysmenorrhea accounted for 33.19%, which accounted for 45.73% mild, moderate total 38.81 percent, accounting for 13.55% of severe ; girls accounted for 75% of primary dysmenorrhea. , Showed the incidence of domestic dysmenorrhea is increasing. Various reports indicate that about 30% to 60% of women suffer during menstruation or dysmenorrhea, premenstrual syndrome troubles, about 10% of women have symptoms affecting normal life, the data show that nearly 64% of women buy their own OTC drugs to relieve pain.
A population of 60,189 million Chinese women, of which 34,185 million people of childbearing age, according to the lowest incidence rate of 33.19% dysmenorrhea calculated, dysmenorrhea, there were 11,346 people, according to the quark (China) consultancy market research firm in 17 major Chinese coastal medium-sized cities, the research shows: Every year, 5.1 billion Tiaojing drug market capacity and spending power, while China will produce at least 20 billion yuan every year about dysmenorrhea care market.
200 billion market, such a splendid feast, who can take a slice? Alleviate many PMS drugs, painkillers and diuretics compound Preparation Is more common to use an OTC medication, such compound 1998 Preparation Sales in the United States 600 million, the pursuit of a higher quality of life as people's awareness and improve drug safety, such OTC drug sales will increase. According to Bayer from 2000 to 2001 and 2004, sales of Chattem Inc. infer the number of acetaminophen Pamabrom: dysmenorrhea and premenstrual syndrome OTC drugs, annual sales amounted to 3.3 billion U.S. dollars. As adult women in China's large population base, fewer varieties of treatment of such diseases, therefore, developed a new treatment of the disease compound, will have good social and economic benefits.
Present, the domestic treatment of dysmenorrhea and premenstrual syndrome are mostly proprietary Chinese medicines. Proprietary Chinese medicines because there is too much smell, taste good, taking the long course of treatment, drug taking large amount of defects can not quickly ease the symptoms, the patient is not willing to take. So much western medicine for the treatment of dysmenorrhea in patients of all ages.
1988 , FDA allows three kinds of non-prescription diuretic: caffeine, ammonium chloride and Pamabrom treatment for the menstrual period. Although caffeine has been used as a diuretic, the diuretic effect, but it is not strong, but also lead to excitement, insomnia and other side effects. European authorities are specified using ammonium chloride, bromide and Hydrochlorothiazide Parma plug for the period of urine diuretic, but the latter is a potent diuretic drugs, so do not advocate a non- Prescription drugs Material. To about 200 billion market, Pamabrom occupy the time, location, and is undoubtedly the most promising varieties.
As Henan Svejk Pharmaceutical Co., Ltd. successfully developed the first lead for the treatment of dysmenorrhea and premenstrual syndrome compound class preparations, paracetamol tablets Pamabrom filled a special treatment of this disease in western blank. The drug can effectively eliminate menstrual pain, and can eliminate menstrual water retention and mood changes caused by a variety of clinical symptoms, with the treatment of premenstrual syndrome and the role of primary dysmenorrhea. Pamabrom for the treatment of these symptoms for over 50 years of clinical history, its efficacy and safety of FDA and has been confirmed by long-term clinical application.
I am China Manufacturers writer, reports some information about nonstick electric wok , carbon steel wok set.
Processing your request, Please wait....
